Leonteq Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$80.1K Buy
928
+379
+69% +$33.7K ﹤0.01% 702
2026
Q2
$49.7K Sell
549
-1,340
-71% -$112K ﹤0.01% 805
2026
Q1
$151K Buy
1,889
+1,142
+153% +$94.2K 0.01% 648
2025
Q4
$63.7K Sell
747
-183
-20% -$15K ﹤0.01% 908
2025
Q3
$72.3K Buy
930
+30
+3% +$2.34K ﹤0.01% 820
2025
Q2
$70.4K Sell
900
-2,012
-69% -$150K ﹤0.01% 785
2025
Q1
$211K Sell
2,912
-3,190
-52% -$228K 0.01% 534
2024
Q4
$452K Sell
6,102
-32,540
-84% -$2.28M 0.03% 377
2024
Q3
$2.55M Buy
38,642
+16,694
+76% +$1.21M 0.19% 110
2024
Q2
$2.03M Sell
21,948
-25
-0.1% -$2.21K 0.14% 132
2024
Q1
$2.1M Sell
21,973
-7,714
-26% -$648K 0.16% 148
2023
Q4
$2.26M Sell
29,687
-3,245
-10% -$226K 0.13% 149
2023
Q3
$2.28M Buy
32,932
+10,480
+47% +$842K 0.13% 164
2023
Q2
$2.12M Sell
22,452
-6,795
-23% -$591K 0.11% 188
2023
Q1
$2.42M Sell
29,247
-8,956
-23% -$704K 0.11% 166
2022
Q4
$2.85M Buy
38,203
+10,453
+38% +$806K 0.11% 149
2022
Q3
$2.29M Buy
27,750
+2,881
+12% +$277K 0.09% 169
2022
Q2
$2.36M Buy
24,869
+2,962
+14% +$307K 0.09% 180
2022
Q1
$2.58M Buy
21,907
+310
+1% +$34.8K 0.09% 170
2021
Q4
$2.8M Buy
21,597
+1,288
+6% +$150K 0.1% 173
2021
Q3
$2.3M Sell
20,309
-233
-1% -$26.6K 0.1% 179
2021
Q2
$2.13M Sell
20,542
-1,667
-8% -$157K 0.13% 150
2021
Q1
$1.86M Sell
22,209
-871
-4% -$73.6K 0.11% 161
2020
Q4
$2.11M Buy
+23,080
New +$1.91M 0.11% 156

Other funds holding EW

Leonteq Securities's EW Position: Q3 2026 in Review

Leonteq Securities increased its Edwards Lifesciences (EW) stake by 69% in Q3 2026, buying an estimated $33.7K and bringing the position to 928 shares worth $80.1K. The position accounts for ﹤0.01% of the portfolio, ranked #702.

Leonteq Securities first reported a position in EW in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.85M in Q4 2022. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Leonteq Securities held 928 shares of Edwards Lifesciences worth $80.1K as of Q3 2026.
  • Leonteq Securities bought 379 Edwards Lifesciences shares in Q3 2026, an estimated $33.7K.
  • Edwards Lifesciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #702 holding.
  • Leonteq Securities first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 24 quarters since.
  • Leonteq Securities's Edwards Lifesciences position peaked at $2.85M in Q4 2022.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.